引用本文: | 夏忠军, 李文瑜. 无论诱导阶段是否曾使用过利妥昔单抗维持治疗均可改善复发/难治滤泡性淋巴瘤临床预后Ⅲ期随机对照研究的评价[J]. 循证医学, 2007, 7(1): 20-22. DOI: 10.3969/j.issn.1671-5144.2007.01.008 |
Citation: | XIA Zhong-jun, LI Wen-yu. Evaluation of the Rituximab Maintenance Improves Clinical Outcome of Relapsed/Resistant Follicular Non Hodgkin's Lymphoma, Both in Patients with and without Rituximab during Induction: Results of A Prospective Randomized Phase Ⅲ Intergroup Trial[J]. Journal of Evidence-Based Medicine, 2007, 7(1): 20-22. DOI: 10.3969/j.issn.1671-5144.2007.01.008 |